The Clinical Trials on Alzheimer's Disease (CTAD) conference kicks off in Madrid this month and ATRI leadership is excited to be involved with many of the sessions. CTAD is the only conference that brings together the world’s leading AD/ADRD clinical trialists working in academia, industry, and not-for-profit organizations and has a focus on Alzheimer’s Disease therapeutic trials.
Below you'll find a list of key sessions the ATRI leadership helped make possible, and which will provide unique insights into some of the work being done by ATRI and their collaborators. You can register to attend the event virtually here. And you can view the entire CTAD conference schedule here.
Tuesday, Oct 29th
Friday, Nov 1st
CTAD is also dedicated to promoting the professional development of early career investigators on a career track as an AD/ADRD therapeutic trials clinical investigator or principal investigator. On Wednesday, October 30th at 10:20 a.m., Robert Rissman will co-moderate Showcase A for early career investigators, on Thursday, October 31st at 10:55 a.m., Rema Raman will co-moderate Showcase C, and on Thursday, October 31st at 3:55 p.m., Mike Rafii will co-moderate Showcase D.